Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP816115.RA6UQpPtYdQUf9uqbFzAGuEml7wOBV2v2T3Gxyl-KhPI0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP816115.RA6UQpPtYdQUf9uqbFzAGuEml7wOBV2v2T3Gxyl-KhPI0130_assertion type Assertion NP816115.RA6UQpPtYdQUf9uqbFzAGuEml7wOBV2v2T3Gxyl-KhPI0130_head.
- NP816115.RA6UQpPtYdQUf9uqbFzAGuEml7wOBV2v2T3Gxyl-KhPI0130_assertion description "[In myeloid leukemias, KOR-SA3544 was positive (16/56) only in patients with acute myeloid leukemia with FAB-M2 and overt leukemia following myelodysplastic syndrome, but neither with other types of myeloid leukemias nor with blast crisis in chronic myelogenous leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP816115.RA6UQpPtYdQUf9uqbFzAGuEml7wOBV2v2T3Gxyl-KhPI0130_provenance.
- NP816115.RA6UQpPtYdQUf9uqbFzAGuEml7wOBV2v2T3Gxyl-KhPI0130_assertion evidence source_evidence_literature NP816115.RA6UQpPtYdQUf9uqbFzAGuEml7wOBV2v2T3Gxyl-KhPI0130_provenance.
- NP816115.RA6UQpPtYdQUf9uqbFzAGuEml7wOBV2v2T3Gxyl-KhPI0130_assertion SIO_000772 7543176 NP816115.RA6UQpPtYdQUf9uqbFzAGuEml7wOBV2v2T3Gxyl-KhPI0130_provenance.
- NP816115.RA6UQpPtYdQUf9uqbFzAGuEml7wOBV2v2T3Gxyl-KhPI0130_assertion wasDerivedFrom befree-20140225 NP816115.RA6UQpPtYdQUf9uqbFzAGuEml7wOBV2v2T3Gxyl-KhPI0130_provenance.
- NP816115.RA6UQpPtYdQUf9uqbFzAGuEml7wOBV2v2T3Gxyl-KhPI0130_assertion wasGeneratedBy ECO_0000203 NP816115.RA6UQpPtYdQUf9uqbFzAGuEml7wOBV2v2T3Gxyl-KhPI0130_provenance.